Anti-Müllerian hormone concentrations and parity in fertile women: the model of oocyte donors

S Catteau-Jonard, M Roux, A Dumont… - Reproductive …, 2017 - Elsevier
In France until the end of 2015, oocyte donors must have had at least one child and be aged
18–37 years. This population of fertile women was selected to examine whether serum anti …

Anti-Müllerian hormone concentrations and parity in fertile women: the model of oocyte donors

S Catteau-Jonard, M Roux, A Dumont… - Reproductive …, 2017 - rbmojournal.com
In France until the end of 2015, oocyte donors must have had at least one child and be aged
18–37 years. This population of fertile women was selected to examine whether serum anti …

Anti-Müllerian hormone concentrations and parity in fertile women: the model of oocyte donors

S Catteau-Jonard, M Roux, A Dumont… - Reproductive …, 2017 - infona.pl
In France until the end of 2015, oocyte donors must have had at least one child and be aged
18–37 years. This population of fertile women was selected to examine whether serum anti …

Anti-Müllerian hormone concentrations and parity in fertile women: the model of oocyte donors

S Catteau-Jonard, M Roux, A Dumont, AS Delesalle… - 2017 - hal.science
In France until the end of 2015, oocyte donors must have had at least one child and be aged
18-37 years. This population of fertile women was selected to examine whether serum anti …

Anti-Müllerian hormone concentrations and parity in fertile women: the model of oocyte donors

S Catteau-Jonard, M Roux… - Reproductive …, 2017 - pubmed.ncbi.nlm.nih.gov
In France until the end of 2015, oocyte donors must have had at least one child and be aged
18-37 years. This population of fertile women was selected to examine whether serum anti …

Anti-Müllerian hormone concentrations and parity in fertile women: the model of oocyte donors.

S Catteau-Jonard, M Roux, A Dumont… - Reproductive …, 2017 - europepmc.org
In France until the end of 2015, oocyte donors must have had at least one child and be aged
18-37 years. This population of fertile women was selected to examine whether serum anti …